Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Carcinogenesis

• Publication date

  1991-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/CARCIN/12.10.1857PMID 1657427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of O6-alkylguanine in cell killing and mutagenesis in Chinese hamster ovary cells.

  1991cited by this paper
• Relative efficiencies of the bacterial, yeast, and human DNA methyltransferases for the repair of O6-methylguanine and O4-methylthymine. Suggestive evidence for O4-methylthymine repair by eukaryotic methyltransferases.

  1991cited by this paper
• Physicochemical studies of human O6-methylguanine-DNA methyltransferase.

  1990cited by this paper
• DNA repair and chromosomal stability in the alkylating agent-hypersensitive Chinese hamster cell line 27-1.

  1990cited by this paper
• Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents.

  1990cited by this paper
• Immunoaffinity purification of human O6-alkylguanine-DNA alkyltransferase using newly developed monoclonal antibodies.

  1990cited by this paper
• Repair of O6-ethylguanine in DNA protects rat 208F cells from tumorigenic conversion by N-ethyl-N-nitrosourea.

  1990cited by this paper
• Purification, structure, and biochemical properties of human O6-methylguanine-DNA methyltransferase.

  1990cited by this paper
• Isolation and structural characterization of a cDNA clone encoding the human DNA repair protein for O6-alkylguanine

  1990cited by this paper
• Overexpressed human metallothionein IIA gene protects Chinese hamster ovary cells from killing by alkylating agents.

  1990cited by this paper
• Expression and cloning of complementary DNA for a human enzyme that repairs O6-methylguanine in DNA.

  1990cited by this paper
• Age-dependent modulation of tissue-specific repair activity for 3-methyladenine and O6-methylguanine in DNA in inbred mice.

  1989cited by this paper
• Increase in nitrosourea resistance in mammalian cells by retrovirally mediated gene transfer of bacterial O6-alkylguanine-DNA alkyltransferase.

  1989cited by this paper
• Expression of mammalian O6-alkylguanine-DNA alkyltransferase in a cell line sensitive to alkylating agents.

  1989cited by this paper
• The relationship between O6-alkylguanine alkyltransferase activity and sensitivity to alkylation-induced sister chromatid exchanges in human lymphoblastoid cell lines.

  1989cited by this paper
• Properties of N-methyl-N-nitrosourea-resistant, Mex- derivatives of an SV40-immortalized human fibroblast cell line.

  1989cited by this paper
• Cell specific differences in O6-methylguanine-DNA methyltransferase activity and removal of O6-methylguanine in rat pulmonary cells.

  1988cited by this paper
• The contribution of O6-methylguanine and methylphosphotriesters to the cytotoxicity of alkylating agents in mammalian cells.

  1988cited by this paper
• Mutagenic potential of modified DNA precursors in vivo: fate of O6-methyldeoxyguanosine triphosphate in Chinese hamster ovary cells.

  1988cited by this paper
• Repair of O-alkylpyrimidines in mammalian cells: a present consensus.

  1988cited by this paper
• Regulation and expression of the adaptive response to alkylating agents.

  1988cited by this paper
• Difference in O6-methylguanine methyltransferase activity among transformed NIH3T3 cell clones.

  1987cited by this paper
• Correction of alkylation hypersensitivity of CHO-W27-1 cells by transfection with human DNA.

  1987cited by this paper
• DNA alkylation repair and the induction of cell death and sister chromatid exchange in human cells.

  1987cited by this paper
• Transfectant CHO cells expressing O6-alkylguanine-DNA-alkyltransferase display increased resistance to DNA damage other than O6-guanine alkylation.

  1987cited by this paper
• Comparative analysis of O6-methylguanine methyltransferase activity and cellular sensitivity to alkylating agents in cell strains derived from a variety of animal species.

  1987cited by this paper
• Expression of the truncated E. coli O6-methylguanine methyltransferase gene in repair-deficient human cells and restoration of cellular resistance to alkylating agents.

  1987cited by this paper
• Transfer of human genes conferring resistance to methylating mutagens, but not to UV irradiation and cross-linking agents, into Chinese hamster ovary cells

  1987cited by this paper
• MNNG-induced partial phenotypic reversion of Mer- cells.

  1987cited by this paper
• Cytotoxicity, mutations and SCEs induced by methylating agents are reduced in CHO cells expressing an active mammalian O6-methylguanine-DNA methyltransferase gene.

  1987cited by this paper
• Analysis of repair processes by the determination of the induction of cell killing and mutations in two repair-deficient Chinese hamster ovary cell lines.

  1986cited by this paper
• The intracellular signal for induction of resistance to alkylating agents in E. coli.

  1986cited by this paper
• Reduction of the toxicity and mutagenicity of alkylating agents in mammalian cells harboring the Escherichia coli alkyltransferase gene.

  1986cited by this paper
• Complementation of sensitivity to alkylating agents in Escherichia coli and Chinese hamster ovary cells by expression of a cloned bacterial DNA repair gene.

  1986cited by this paper
• Suppression of human DNA alkylation-repair defects by Escherichia coli DNA-repair genes.

  1986cited by this paper
• Transfer of the E. coli O6-methylguanine methyltransferase gene into repair-deficient human cells and restoration of cellular resistance to N-methyl-N'-nitro-N-nitrosoguanidine.

  1986cited by this paper
• Expression in mammalian cells of a truncated Escherichia coli gene coding for O6-alkylguanine alkyltransferase reduces the toxic effects of alkylating agents.

  1986cited by this paper
• Comparison of O6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues.

  1986cited by this paper
• Chinese hamster cells harbouring the Escherichia coli O6-alkylguanine alkyltransferase gene are less susceptible to sister chromatid exchange induction and chromosome damage by methylating agents.

  1986cited by this paper
• Cellular defence mechanisms against alkylating agents.

  1985cited by this paper
• Methylation-induced blocks to in vitro DNA replication.

  1985cited by this paper
• In vitro miscoding of alkylthymines with DNA and RNA polymerases.

  1985cited by this paper
• Dependency of the yield of sister-chromatid exchanges induced by alkylating agents on fixation time. Possible involvement of secondary lesions in sister-chromatid exchange induction.

  1985cited by this paper
• Methyl phosphotriesters in alkylated DNA are repaired by the Ada regulatory protein of E. coli.

  1985cited by this paper
• Mechanisms of carcinogenesis induced by alkylating agents.

  1985cited by this paper
• Studies of the repair of O6-alkylguanine and O4-alkylthymine in DNA by alkyltransferases from mammalian cells and bacteria.

  1985cited by this paper
• Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.

  1985cited by this paper
• The role of O6-methylguanine-DNA methyltransferase in cell survival, mutagenesis and carcinogenesis.

  1985cited by this paper
• Genetic and molecular mechanisms of the in vitro transformation of Syrian hamster embryo cells by the carcinogen N-ethyl-N-nitrosourea II. Correlation of morphological transformation, enhanced fibrinolytic activity, gene mutations, chromosomal alterations and lethality to specific carcinogen-induced

  1985cited by this paper
• The cytotoxic and mutagenic effects of alkylating agents on human lymphoid cells are caused by different DNA lesions.

  1985cited by this paper
• Depletion of O6-methylguanine-DNA-methyltransferase in human fibroblasts increases the mutagenic response to N-methyl-N'-nitro-N-nitrosoguanidine.

  1985cited by this paper
• Mechanism of mutagenesis by O6-methylguanine

  1984cited by this paper
• Mutagenic and genotoxic effects of O6-methylguanine: a revision.

  1984cited by this paper
• O6-Methylguanine-DNA methyltransferase in human cells.

  1984cited by this paper
• O6-alkylguanine-DNA alkyltransferase activity in normal human tissues and cells.

  1984cited by this paper
• Lack of induction of O6-methylguanine-DNA methyltransferase in mammalian cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.

  1984cited by this paper
• Inducible repair of O‐alkylated DNA pyrimidines in Escherichia coli.

  1984cited by this paper
• Biological effects of incorporation of O6-methyldeoxyguanosine into Chinese hamster V79 cells.

  1983cited by this paper
• Repair of O6-methylguanine in DNA by demethylation is lacking in Mer- human tumor cell strains.

  1983cited by this paper
• O6-Methylguanine-DNA methyltransferase of human lymphoid cells: structural and kinetic properties and absence in repair-deficient cells.

  1983cited by this paper
• Purification and properties of O6-methylguanine-DNA transmethylase from rat liver.

  1983cited by this paper
• Studies on adaptation of V79 Chinese hamster cells to low doses of methylating agents.

  1983cited by this paper
• Alkylation-induced sister-chromatid exchanges correlate with reduced cell survival, not mutations.

  1982cited by this paper
• Induction of a DNA glycosylase for N-methylated purines is part of the adaptive response to alkylating agents

  1982cited by this paper
• Repair of alkylated DNA in Escherichia coli. Physical properties of O6-methylguanine-DNA methyltransferase.

  1982cited by this paper
• A common mechanism for repair of O6-methylguanine and O6-ethylguanine in DNA.

  1982cited by this paper
• Removal of O6-methylguanine from DNA of normal and xeroderma pigmentosum-derived lymphoblastoid lines

  1981cited by this paper
• Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains

  1980cited by this paper
• Demethylation of O6-methylguanine in a synthetic DNA polymer by an inducible activity in Escherichia coli.

  1980cited by this paper
• DNA synthesis with methylated poly(dC-dG) templates. Evidence for a competitive nature to miscoding by O(6)-methylguanine.

  1979cited by this paper
• The relation between reaction kinetics and mutagenic action of mono-functional alkylating agents in higher eukaryotic systems. I. Recessive lethal mutations and translocations in Drosophila.

  1979cited by this paper
• Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

  1977cited by this paper
• Persistence of O6-ethylguanine in rat-brain DNA: correlation with nervous system-specific carcinogenesis by ethylnitrosourea.

  1974cited by this paper
• Carcinogenicity of N-methyl-N-nitrosourea: possible role of excision repair of O6-methylguanine from DNA.

  1974cited by this paper
• Possible Relevance of O–6 Alkylation of Deoxyguanosine to the Mutagenicity and Carcinogenicity of Nitrosamines and Nitrosamides

  1969cited by this paper

• Senotherapeutics in Malignant Brain Cancer Therapy

  2025cites this paper
• PARP1 promotes replication-independent DNA double-strand break formation after acute DNA-methylation damage

  2025cites this paper
• Impact of MGMT methylation on overall survival in solid tumors: A systematic review and meta-analysis

  2025cites this paper
• Lack of mismatch repair enhances resistance to methylating agents for cells deficient in oxidative demethylation

  2024cites this paper
• Temozolomide, Procarbazine and Nitrosoureas in the Therapy of Malignant Gliomas: Update of Mechanisms, Drug Resistance and Therapeutic Implications

  2023cites this paper
• Dose response to methylating agents in the γH2AX, SCE and colony formation assays: Effect of MGMT and MPG overexpression.

  2022cites this paper
• The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies

  2022cites this paper
• Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells

  2022cites this paper
• Temozolomide – Just a Radiosensitizer?

  2022cites this paper
• Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance

  2021cites this paper
• Molecular Dosimetry of Temozolomide: Quantification of Critical Lesions, Correlation to Cell Death Responses, and Threshold Doses

  2021cites this paper
• Permitted daily exposure limits for noteworthy N‐nitrosamines

  2021cites this paper
• Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy

  2021cites this paper
• Mode of action-based risk assessment of genotoxic carcinogens

  2020influential citation
• Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy. Comment on Strobel et al., Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines 2019, 7, 69

  2019cites this paper
• AID, APOBEC3A and APOBEC3B efficiently deaminate deoxycytidines neighboring DNA damage induced by oxidation or alkylation.

  2019cites this paper
• Microcolony Size Distribution Assay Enables High-Throughput Cell Survival Quantitation

  2019cites this paper
• The mismatch repair-dependent DNA damage response: Mechanisms and implications.

  2019cites this paper
• Interferon-β sensitizes human malignant melanoma cells to temozolomide-induced apoptosis and autophagy.

  2019cites this paper
• Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?

  2019cites this paper
• Repair and translesion synthesis of O6-alkylguanine DNA lesions in human cells

  2019cites this paper
• MutT homologue 1 (MTH1) catalyzes the hydrolysis of mutagenic O6-methyl-dGTP

  2018cites this paper
• Context Matters: Contribution of Specific DNA Adducts to the Genotoxic Properties of the Tobacco-Specific Nitrosamine NNK.

  2017cites this paper
• Chloroethylating nitrosoureas in cancer therapy: DNA damage, repair and cell death signaling.

  2017cites this paper
• Environment‐sensitive Fluorescent Turn‐on Chemical Probe for the Specific Detection of O‐Methylguanine‐DNA Methyltransferase (MGMT) in Living Cells

  2016cites this paper
• DNA Repair and its influence on points of departure for alkylating agent genotoxicity

  2016cites this paper
• Measurement of O(6)-alkylguanine-DNA alkyltransferase activity in tumour cells using stable isotope dilution HPLC-ESI-MS/MS.

  2016cites this paper
• Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs

  2016cites this paper
• The bacterial alkyltransferase-like (eATL) protein protects mammalian cells against methylating agent-induced toxicity.

  2015cites this paper
• Theoretical considerations for thresholds in chemical carcinogenesis.

  2015cites this paper
• Decoy Receptor DcR1 Is Induced in a p50/Bcl3-Dependent Manner and Attenuates the Efficacy of Temozolomide.

  2015cites this paper
• Protein sensing in living cells by molecular rotor-based fluorescence-switchable chemical probes

  2015cites this paper
• miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1.

  2015cites this paper
• A Novel Temozolomide–Perillyl Alcohol Conjugate Exhibits Superior Activity against Breast Cancer Cells In Vitro and Intracranial Triple-Negative Tumor Growth In Vivo

  2014cites this paper
• Does increase in DNA repair allow “Tolerance‐to‐Insult” in chemical carcinogenesis? Skin tumor experiments with MGMT‐overexpressing mice

  2014cites this paper
• B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells

  2014cites this paper
• Combination Treatment with Theranostic Nanoparticles for Glioblastoma Sensitization to TMZ

  2014cites this paper
• O6-methylguanine-DNA methyltransferase in the defense against N-nitroso compounds and colorectal cancer.

  2013cites this paper
• DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis.

  2013cites this paper
• Role of aldehydes in the toxic and mutagenic effects of nitrosamines.

  2013cites this paper
• Contribution of ATM and ATR to the Resistance of Glioblastoma and Malignant Melanoma Cells to the Methylating Anticancer Drug Temozolomide

  2013cites this paper
• PERSISTENCIA DE LAS LESIONES CAUSADAS AL ADN POR AGENTES ALQUILANTES, INVOLUCRADAS EN LA PRODUCCIÓN DE INTERCAMBIOS EN LAS CROMÁTIDAS HERMANAS

  2013cites this paper
• LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2.

  2013cites this paper
• O6-Methylguanine-DNA Methyltransferase (MGMT) in Cancer Protection and Therapy

  2013cites this paper
• Influence of DNA Repair on Nonlinear Dose-Responses for Mutation

  2013cites this paper
• In vivo Comparative Studies on Antigenotoxicity of Date Palm (Phoenix Dactylifera L.) Pits Extract Against DNA Damage Induced by N-Nitroso-N-methylurea in Mice

  2012cites this paper
• Balancing repair and tolerance of DNA damage caused by alkylating agents

  2012cites this paper
• The novel DNA alkylating agent BO‐1090 suppresses the growth of human oral cavity cancer in xenografted and orthotopic mouse models

  2012cites this paper
• Molecular biology of glioma.

  2012cites this paper
• Probing the binding of interstrand crosslinked DNA containing a fluorescent base analog with human and E. coli homologs of O6-alkyl-guanine-DNA-alkyltransferase

  2012cites this paper
• The promoter methylation and expression of the O6-methylguanine-DNA methyltransferase gene in uterine sarcoma and carcinosarcoma.

  2012cites this paper
• 7-azabicyclo[2.2.1]heptane as a structural motif to block mutagenicity of nitrosamines.

  2011cites this paper
• Effect of temozolomide on cell viability in gonadotroph adenoma cell lines.

  2011cites this paper
• Intrinsic anticancer drug resistance of malignant melanoma cells is abrogated by IFN-β and valproic acid.

  2011cites this paper
• DNA mismatch repair and cellular response to cytarabine : implications for the pathogenesis and treatment of therapy-related acute myeloid leukaemia

  2011cites this paper
• A rapid survival assay to measure drug-induced cytotoxicity and cell cycle effects.

  2011cites this paper
• Rad51 and BRCA2 - New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer Drugs

  2011cites this paper
• MGMT activity in mucosal epithelium and squamous cell carcinoma of the head and neck.

  2010cites this paper
• QM/MM study on the reaction mechanism of O6-alkylguanine-DNA alkyltransferase.

  2010cites this paper
• Methylated DNA causes a physical block to replication forks independently of damage signalling, O(6)-methylguanine or DNA single-strand breaks and results in DNA damage.

  2010cites this paper
• Homologous recombination protects mammalian cells from replication-associated DNA double-strand breaks arising in response to methyl methanesulfonate.

  2010cites this paper
• Targeting O6-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy

  2010cites this paper
• Activation of AMP-activated Protein Kinase by Temozolomide Contributes to Apoptosis in Glioblastoma Cells via p53 Activation and mTORC1 Inhibition*

  2010cites this paper
• Processing of O6-methylguanine into DNA double-strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles

  2010cites this paper
• Both base excision repair and O6-methylguanine-DNA methyltransferase protect against methylation-induced colon carcinogenesis

  2010cites this paper
• Quantitative relationship between guanine O(6)-alkyl lesions produced by Onrigin™ and tumor resistance by O(6)-alkylguanine-DNA alkyltransferase.

  2010cites this paper
• MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC.

  2010cites this paper
• Analysis of Cellular Factors assisting AGT Regulation

  2009cites this paper
• Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53

  2009cites this paper
• A novel protein, MAPO1, that functions in apoptosis triggered by O6-methylguanine mispair in DNA

  2009cites this paper
• Roles of polysaccharide from Branchiostoma belcheri in anti-DNA oxidation and anti-tumor activity in S180 mice

  2009cites this paper
• Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O(6)-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs.

  2009cites this paper
• Actual and potential agents and biomarkers in the treatment of cancer.

  2009cites this paper
• Reduced methylation-induced mutagenesis in rat splenocytes in vivo by sub-chronic low dose exposure to N-metyl-N-nitrosourea.

  2008cites this paper
• Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity.

  2008cites this paper
• Mecanismos de indução de apoptose pela presença de danos ao DNA: Um estudo sobre o papel de p53 na resistência de células de glioma a agentes quimioterápicos

  2008cites this paper
• Alterations in S-adenosylhomocysteine metabolism decrease O6-methylguanine DNA methyltransferase gene expression without affecting promoter methylation.

  2008cites this paper
• Live and let die: in vivo selection of gene-modified hematopoietic stem cells via MGMT-mediated chemoprotection.

  2007cites this paper
• Effect of ethanol extract of alga Laurencia supplementation on DNA oxidation and alkylation damage in mice.

  2007cites this paper
• Tamoxifen accelerates proteasomal degradation of O6‐methylguanine DNA methyltransferase in human cancer cells

  2007cites this paper
• MGMT: a personal perspective.

  2007cites this paper
• Drug Resistance in Lung Cancer

  2007cites this paper
• Glioblastoma multiforme: the role of DSB repair between genotype and phenotype

  2007cites this paper
• Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine

  2007cites this paper
• Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosis.

  2007cites this paper
• Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.

  2007cites this paper
• Local intracerebral administration of O6-benzylguanine combined with systemic chemotherapy with temozolomide of a patient suffering from a recurrent glioblastoma

  2007cites this paper
• MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.

  2007cites this paper
• DNA Methylation Damage: Formation, Repair and Biological Consequences

  2007cites this paper
• - nitrosourea N-Bis ( 2-chloroethyl )-′ N , N-Benzylguanine to Killing by 6 O Alkyltransferase Prevent the Sensitization by-Alkylguanine-DNA 6 O Point Mutations in Human Updated

  2006cites this paper
• Alkylguanine-DNA Alkyltransferase Attenuates Triazeneinduced Cytotoxicity and Tumor Cell Immunogenicity in Murine L 1210 Leukemia '

  2006cites this paper
• Kaina by Oxidative Stress and Involved in Clastogenic Adaptation Apurinic Endonuclease ( Ref-1 ) Is Induced in Mammalian Cells

  2006cites this paper
• C-mediated Signaling-Methylguanine-DNA Methyltransferase via Protein Kinase 6 O Regulation of Expression of the DNA Repair Gene Updated

  2006cites this paper
• Extended Depletion of 06-Methylguanine-DNA Methyltransferase Activity following 06-Benzyl-2'-deoxyguanosine or 06-Benzylguanine Combined with Streptozotocin Treatment Enhances l,3-Bis(2-chloroethyl)-l-nitrosourea Cytotoxicity1

  2006cites this paper
• O6‐methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

  2006influential citation
• Methylation of the O6‐methylguanine‐DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol

  2006cites this paper
• Xrcc2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamide.

  2006cites this paper
• The alkylating carcinogen N-methyl-N’-nitro-N-nitrosoguanidine activates the plasminogen activator inhibitor-1 gene through sequential phosphorylation of p53 by ATM and ATR kinases

  2005cites this paper
• Engineering Substrate Specificity of O6‐Alkylguanine‐DNA Alkyltransferase for Specific Protein Labeling in Living Cells

  2005cites this paper
• Role of 06-Methylguanine-DNA Methyltransferase in Resistance of Human Brain Tumor Cell Lines to the Clinically Relevant Methylating Agents Temozolomide and Streptozotocin1

  2005cites this paper